Genmab — Juli 2019

[Plimsoller]

Concerning the TV trial, is the answer not just to send an email to Genmab and ask?

[Solsen]

I would not be surpriced if they narrow the targets and downplay TV. I belive they more want to use their money on the hexabody technology.

[E_L]

@Plimsoller not sure it has to be a concern, could be a change in design of the trials or the direction, but i think a good question for Q&A?

[peter12]

De vil bruge 100 mio$ på TV https://www.nasdaq.com/markets/ipos/company/genmab-as-777502-89779

[E_L]

@Solsen they have not given any indications for that (yet...) though?

[E_L]

exactly peter , and it was prominently in their pipeline each time so far.

[peter12]

TV is doing good in bladder but SGEN have a similar drug ?

[Legolas23]

Hvis der var givet PR på SC, burde så det så ikke være blevet oplyst?

[Bulder]

Nej, det er for tidligt. Cassiopeia blev indsendt 26. marts og fik PR 30. maj. Så 2 mdr er helt normalt.

[bikube]

peter 12 - TV er jo 50/50 samarbejde med Sgen

[Solsen]

I dont say they will give up TV. Just some indications. Cervix, ovarie and pancreas are interesting. But I dont have a insight in competitive drugs.

[Jedi]

The terminated TV trial - note that it reads “continued treatment with TV” so isn’t it just an offer of continued treatment to responders in the first TV trial? Hence no big deal if it is now shut down

[Bulder]

Agree, no big deal

[Helge_LarsenPI-redaktør]

Luk i dagens højeste.

[Helge_LarsenPI-redaktør]

[Solsen]

Sprut igen

[Legolas23]

Drinks, eller ?

[Solsen]

Hvad der er nærmest. De 1300 kalder på os.

[Helge_LarsenPI-redaktør]

Her i Regstrup er det kold Fleurie til laks og paté med fasan og masser af cornichoner. Det holder maks til 1.275 og skal gentages ved 1.300 i næste uge.

[Solsen]

Ja vi skal huske at glædes over fremgang. Der er nok af påmindelser når det går tilbage